Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THV01 Therapeutic Vaccine in HIV-1 Infected Patients
NCT02054286Phase 2Completed
- Sponsor
- TheraVectys
- Start
- Dec 2012
- Primary completion
- Aug 2014
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 2
01
Overview
A Phase 2 trial of THV01-2 in human immunodeficiency virus infection (HIV), sponsored by TheraVectys. Started Dec 2012; status: completed.
02
Drugs
THV01-2
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02054286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054286.